MCRB (STOCKS)
Seres Therapeutics, Inc.
$4.540000
+0.060000 (+1.34%)
Prev close: $4.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Richard N. Kender, MBA
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $44.57M
- Employees
- 103
- P/E (TTM)
- -1.99
- P/B (TTM)
- 1.29
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.50 | $-2.23 | +0.7287 | +32.70% |
|
Mar 2026 (Q1)
|
$-2.08 | $-1.92 | -0.1624 | -8.47% |
|
Dec 2025 (Q4)
|
$-1.78 | $-2.15 | +0.3722 | +17.29% |
|
Sep 2025 (Q3)
|
$0.94 | $1.31 | -0.3656 | -28.00% |
Financial Statements
| Revenues | $1.88M |
| Benefits Costs and Expenses | $7.92M |
| Costs And Expenses | $51.19M |
| Nonoperating Income/Loss | $61.57M |
| Operating Expenses | $85.92M |
| Research and Development | $46.64M |
| Other Operating Expenses | $39.28M |
| Operating Income/Loss | -$84.03M |
| Income/Loss From Continuing Operations After Tax | -$22.46M |
| Income/Loss From Continuing Operations Before Tax | -$26.31M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$22.46M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.46M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.42 |
| Diluted Earnings Per Share | -$2.41 |
| Basic Average Shares | 18,526,953 |
| Diluted Average Shares | 18,541,168 |
| Assets | $101.59M |
| Current Assets | $42.35M |
| Noncurrent Assets | $59.24M |
| Fixed Assets | $5.80M |
| Other Non-current Assets | $53.44M |
| Liabilities | $67.05M |
| Current Liabilities | $20.03M |
| Accounts Payable | $1.19M |
| Wages | $2.23M |
| Other Current Liabilities | $16.62M |
| Noncurrent Liabilities | $47.02M |
| Equity | $34.53M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $34.53M |
| Liabilities And Equity | $101.59M |
| Net Cash Flow From Operating Activities | -$51.26M |
| Net Cash Flow From Operating Activities, Continuing | -$51.26M |
| Net Cash Flow From Investing Activities | $187.00K |
| Net Cash Flow From Investing Activities, Continuing | $187.00K |
| Net Cash Flow From Financing Activities | $14.86M |
| Net Cash Flow From Financing Activities, Continuing | $14.86M |
| Net Cash Flow | -$36.21M |
| Net Cash Flow, Continuing | -$36.21M |
| Comprehensive Income/Loss | -$22.46M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.46M |
| Other Comprehensive Income/Loss | $5.70M |